Traders should monitor for the closing of the merger in Q2 2026, which will result in a ticker change from COEP/COEPW to ZSQR and a strategic shift from biopharmaceuticals to cryptocurrency mining. The lack of financial details about the merger terms creates uncertainty despite this positive listing development.
Price Chart
Executive Summary
Coeptis Therapeutics announced that Nasdaq has approved, subject to customary conditions, the listing of the post-merger company's common stock under the new ticker ZSQR following its merger with Z Squared Inc. This approval satisfies a key closing condition for the pending business combination.
Key Facts
- Nasdaq approved the listing of the post-merger company's common stock under ticker ZSQR
- Approval is subject to customary conditions and closing of the merger with Z Squared Inc.
- Merger remains subject to remaining customary closing conditions with no assurance they will be satisfied
- Transaction is expected to close in Q2 2026
- Post-merger entity will change its corporate name to Z Squared Inc.
Financial Impact
Undisclosed amount related to the merger transaction
Risk Factors
- Merger may not close despite Nasdaq approval
- No disclosure of financial terms or valuation in this filing
- Strategic shift from biopharma to crypto mining carries execution risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001683168-26-002726 |
| Document: coeptis_ex9901.htm | 0001683168-26-002726 |
| Document: 0001683168-26-002726-index-headers.html | 0001683168-26-002726 |
| Document: 0001683168-26-002726-index.html | 0001683168-26-002726 |
| Document: 0001683168-26-002726.txt | 0001683168-26-002726 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 29, 2026 25w ago | 3 | — | awaiting T+20 | — | — |
Apr 24, 2026 26w ago | 25-NSE | $0.0123 | awaiting T+20 | — | — |
Apr 7, 2026 28w ago | 8-K | $0.0123 | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers